Skip to main content

Jose Fernando Rodríguez Palomares

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Jose Fernando Rodríguez Palomares

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

DataTools4Heart: A European Health Data Toolbox for Enhancing Cardiology Data Interoperability, Reusability and Privacy

IP: Jose Fernando Rodríguez Palomares
Collaborators: Alicia Fresno González, Ignacio Ferreira González, Gisela Teixido Tura, Juan Garrido Oliver, Aroa Ruiz Muñoz, Lydia Dux-Santoy Hurtado, Andrea Guala, Andrea Guala, Andrea Guala, Andrea Guala, Andrea Guala, Andrea Guala, Andrea Guala, Andrea Guala, Andrea Guala, Andrea Guala, Andrea Guala, Andrea Guala
Funding agency: EUROPEAN COMMISSION
Funding: 322500
Reference: DATATOOLS4HEART_HE-HLTH-TOOL21
Duration: 01/10/2022 - 30/09/2026

RESULTADOS EN PACIENTES ADULTOS CON VÁLVULA AÓRTICA BICÚSPIDE: PREDICTORES DE DEGENERACIÓN VALVULAR Y DILATACIÓN AÓRTICA BASADOS EN ANOMALÍAS DE FLUJO AÓRTICO Y ACTIVIDAD BIOMECÁNICA Y METABÓLICA.

IP: Jose Fernando Rodríguez Palomares
Collaborators: -
Funding agency: -Sociedad Española de Cardiologia
Funding: 15000
Reference: SEC/INV.CLINICA/2021/RODRIGUEZ
Duration: 27/10/2021 - 26/10/2022

CARdiomyopathy in type 2 DIAbetes mellitus

IP: Jose Fernando Rodríguez Palomares
Collaborators: Ignacio Ferreira González, Macarena Lorente Coppola
Funding agency: EUROPEAN COMMISSION
Funding: 50879.1
Reference: CARDIATEAM_IMI22017
Duration: 01/03/2019 - 28/02/2026

Aneurisma aterosclerótico de aorta torácica descendente y abdominal: predictores biomecánicos, histológicos y hemodinámicos de dilatación aórtica y eventos adversos

IP: Jose Fernando Rodríguez Palomares
Collaborators: Sergi Bellmunt Montoya, Aroa Ruiz Muñoz, Lydia Dux-Santoy Hurtado, Ruperto Olivero Soldevila
Funding agency: Instituto de Salud Carlos III
Funding: 127050
Reference: PI19/01480
Duration: 01/01/2020 - 30/06/2024

Related news

The project aims to improve prevention, diagnosis, and treatment through computational biomedicine, innovative therapies, and the transfer of knowledge into clinical practice.

The second edition of the AI ​​Day served to share knowledge, reflect and chart the future of artificial intelligence applied to research and health.

The study, led by Vall d'Hebron, is the first in Spain to analyse the relationship between pregnancy complications and the risk of long-term cardiovascular diseases.

Related professionals

Tao Gonzalez Zaragoza

Tao Gonzalez Zaragoza

Zelador/a
General Services and Infrastructures Unit
Infrastructure Coordination
Manager
Read more
Cristina Avila Fumanal

Cristina Avila Fumanal

Growth and Development
Read more
Mireia  Beltran  Porres

Mireia Beltran Porres

Growth and Development
Read more
Anna Enrich  Font

Anna Enrich Font

Research technician
Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.